Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

Citation(s) in RCA

1
(from Reference Citation Analysis)

Indexed Articles

Ranked By

Results Analysis

Year Published Analysis
Article Type Analysis
Journal Title Analysis
Category Analysis

Results Analysis

Year Published

Show more Refine

Article Statistics

Refine

Publication Titles

Show more Refine

Category

Show more Refine

For: Stępień A, Nowak W, Stachura T, Marcinek P, Soja J, Sładek K. Impaired humoral immune response in a COVID‑19 patient with chronic lymphocytic leukemia complicated by spontaneous pneumomediastinum and hemophagocytic lymphohistiocytosis syndrome. Pol Arch Intern Med 2021;131. [PMID: 34619954 DOI: 10.20452/pamw.16108] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]

For:	Stępień A, Nowak W, Stachura T, Marcinek P, Soja J, Sładek K. Impaired humoral immune response in a COVID‑19 patient with chronic lymphocytic leukemia complicated by spontaneous pneumomediastinum and hemophagocytic lymphohistiocytosis syndrome. Pol Arch Intern Med 2021;131. [PMID: 34619954 DOI: 10.20452/pamw.16108] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]

Number	Cited by Other Article(s)
1	Convalescent-anti-sars-cov-2-plasma/dexamethasone/rituximab. REACTIONS WEEKLY 2022. [PMCID: PMC8972633 DOI: 10.1007/s40278-022-12462-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Subscribe] [Scholar Register] [Indexed: 12/04/2022] Abstract Collapse Key Words Collapse MESH Headings Collapse Grants Collapse Affiliation(s) Collapse

Number

Cited by Other Article(s)

Convalescent-anti-sars-cov-2-plasma/dexamethasone/rituximab. REACTIONS WEEKLY 2022. [PMCID: PMC8972633 DOI: 10.1007/s40278-022-12462-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Subscribe] [Scholar Register] [Indexed: 12/04/2022]